Cited by 307Advanced Drug Delivery SystemsNanoparticle-Based Drug DeliveryTissue Engineering and Regenerative Medicine

Biocompatibility and drug delivery systems

Kohane, Daniel S., Langer, Robert·2010·Chem. Sci.

Abstract

Drug delivery technology has emerged as an important focus of biotechnological research and commercial enterprise. While much attention is justifiably focused on the design and effectiveness of drug delivery devices, the nature of their interaction with surrounding tissues – their biocompatibility – is crucial. Here we discuss biocompatibility, specifically as it relates to drug delivery systems, which differ from other biomaterial-based devices by possibly containing large quantities of drugs with their own effects on tissues.

Integrity signals

Registry

Crossref · 10.1039/c0sc00203h

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nanometer-sized materials with high biocompatibility and biodegradability are considered excellent drug delivery systems for biomedical applications.

    “Ideally, nanometer-sized materials with high biocompatibility8 and biodegradability9 are considered excellent drug delivery systems for biomedical applications.10”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kohane, D. S., & Langer, R.
Affiliations
Harvard University (US)
Corresponding author
Kohane, Daniel S.
Venue
Chem. Sci.
Published
2010
Volume
1
Issue
4
Pages
441-446
ISSN
  • 2041-6520 (ISSN-L)
  • 2041-6539
OpenAlex
W2076500439
Cited by
307
References
45
Citations by year
2026: 11 · 2025: 23 · 2024: 16 · 2023: 26 · 2022: 18 · 2021: 17 · 2020: 20 · 2019: 17 · 2018: 24 · 2017: 15 · 2016: 17 · 2015: 19 · 2014: 23 · 2013: 15 · 2012: 28
FWCI
13.54
Type
journal article
Language
en
Open access
closed
Locations
Chemical Science (publishedVersion)
Funders
  • National Institute of General Medical Sciences
  • National Institute of Biomedical Imaging and Bioengineering
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
biocompatibility, drug delivery systems, drug delivery devices, biomaterials

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review